Potential impact of metal oxide nanoparticles on the immune system: The role of integrins, L-selectin and the chemokine receptor CXCR4

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 6, 2014, Pages 1301-1310

  Lozano Fernández, Tamara ^a   Ballester Antxordoki, Lidia ^b   Pérez Temprano, Nerea ^b   Rojas, Elena ^c   Sanz, David ^c   Iglesias Gaspar, Maite ^b   Moya, Sergio ^c   González Fernández, África ^a   Rey, Mercedes ^b  

^a UNIVERSITY OF VIGO   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c CIC BIOMAGUNE   (Spain)

Author keywords

CXCR4; Integrin; Lymphocyte; Metal oxide nanoparticles; Selectin

Indexed keywords

ADHESION; ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; BIOCHEMISTRY; CELL PROLIFERATION; IMMUNE SYSTEM; LYMPHOCYTES; MOLECULES; NANOPARTICLES; T-CELLS; TITANIUM DIOXIDE; ZINC OXIDE;

CHEMOKINE RECEPTOR CXCR4; CXCR4; HUMAN PERIPHERAL BLOOD; IMMUNE-MODULATING EFFECTS; INTEGRINS; METAL OXIDE NANOPARTICLES; PROLIFERATIVE RESPONSE; SELECTINS;

METALLIC COMPOUNDS;

ALUMINUM OXIDE NANOPARTICLE; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CERIUM OXIDE NANOPARTICLE; CHEMOKINE RECEPTOR CXCR4; INTEGRIN; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METAL NANOPARTICLE; NANOPARTICLE; PHYTOHEMAGGLUTININ; STROMAL CELL DERIVED FACTOR 1ALPHA; TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE; OXIDE;

ARTICLE; BASOPHIL; BLOOD; CELL ADHESION; CHEMOTAXIS; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; PHAGOCYTOSIS; PROTEIN EXPRESSION; RESPIRATORY BURST; CELL PROLIFERATION; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

CELL PROLIFERATION; CHEMOTAXIS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; METAL NANOPARTICLES; OXIDES; RECEPTORS, CXCR4; RESPIRATORY BURST;

EID: 84905275305     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.03.007     Document Type: Article

References (49)

1. Moyano D.F., et al. Nanoparticle hydrophobicity dictates immune response. J Am Chem Soc 2012, 134(9):3965-3967.
2. Diaz B., et al. Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. Small 2008, 4(11):2025-2034.
3. Lozano T., et al. Cytotoxicity effects of metal oxide nanoparticles in human tumor cell lines. J Phys 2011, 304(1):012046.
4. Kaiser J.P., et al. Single walled carbon nanotubes (SWCNT) affect cell physiology and cell architecture. J Mater Sci Mater Med 2008, 19(4):1523-1527.
5. Li R., et al. Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity. ACS Nano 2013, 7(3):2352-2368.
6. Sengupta J., et al. In vivo interaction of gold nanoparticles after acute and chronic exposures in experimental animal models. J Nanosci Nanotechnol 2013, 13(3):1660-1670.
7. Zhang X.D., et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomedicine 2010, 5:771-781.
8. Coccini T., et al. Apoptosis induction and histological changes in rat kidney following Cd-doped silica nanoparticle exposure: evidence of persisting effects. Toxicol Mech Methods 2013, 23(8):566-575.
9. Coccini T., et al. Pulmonary toxicity of instilled cadmium-doped silica nanoparticles during acute and subacute stages in rats. Histol Histopathol 2013, 28(2):195-209.
10. Gaiser B.K., et al. Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci 2013, 131(2):537-547.
11. Song Y., Li X., Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respir J 2009, 34(3):559-567.
12. Simon-Vazquez R., et al. Conformational changes in human plasma proteins induced by metal oxide nanoparticles. Colloids Surf B Biointerfaces 2013, 113C:198-206.
13. Dobrovolskaia M.A., et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 2008, 5(4):487-495.
14. Pantic I. Nanoparticles and modulation of immune responses. Sci Prog 2011, 94(Pt 1):97-107.
15. Chang C. The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 2010, 34(3):J234-J246.
16. 2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol Appl Pharmacol 2012, 264(1):94-103.
17. Reisetter A.C., et al. Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles. J Biol Chem 2011, 286(24):21844-21852.
18. Fadeel B., Garcia-Bennett A.E. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 2010, 62(3):362-374.
19. Zolnik B.S., et al. Nanoparticles and the immune system. Endocrinology 2010, 151(2):458-465.
20. Vicente S., et al. A polymer/oil based nanovaccine as a single-dose immunization approach. PLoS ONE 2013, 8(4):e62500.
21. Prego C., et al. Chitosan-based nanoparticles for improving immunization against hepatitis B infection. Vaccine 2010, 28(14):2607-2614.
22. Nose K., et al. Gold nanorods in an oil-base formulation for transdermal treatment of type 1 diabetes in mice. Nanoscale 2012, 4(12):3776-3780.
23. Ley K., et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7(9):678-689.
24. Luster A.D., Alon R., von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005, 6(12):1182-1190.
25. Smith C.W. Adhesion molecules and receptors. J Allergy Clin Immunol 2008, 121(2 Suppl):S375-S379. quiz S414.
26. Campbell I.D., Humphries M.J. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol 2011, 3(3):a004994.
27. Bendas G., Borsig L. Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol 2012, 2012:676731.
28. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242.
29. Rottman J.B. Key role of chemokines and chemokine receptors in inflammation, immunity, neoplasia, and infectious disease. Vet Pathol 1999, 36(5):357-367.
30. Salcedo R., Oppenheim J.J. Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation 2003, 10(3-4):359-370.
31. Muller A., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410(6824):50-56.
32. Proudfoot A.E., Wells T.N., Clapham P.R. Chemokine receptors-future therapeutic targets for HIV?. Biochem Pharmacol 1999, 57(5):451-463.
33. Wells T.N., Proudfoot A.E., Power C.A. Chemokine receptors and their role in leukocyte activation. Immunol Lett 1999, 65(1-2):35-40.
34. Karasuyama H., et al. Nonredundant roles of basophils in immunity. Annu Rev Immunol 2011, 29:45-69.
35. Vicente-Manzanares M., et al. Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 alpha-induced lymphocyte polarization and chemotaxis. J Immunol 1999, 163(7):4001-4012.
36. Sanz M.L., et al. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy 2002, 32(2):277-286.
37. Quah B.J., Warren H.S., Parish C.R. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2007, 2(9):2049-2056.
38. Boraschi D., Costantino L., Italiani P. Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine (Lond) 2012, 7(1):121-131.
39. Boscolo P., et al. Effects of palladium nanoparticles on the cytokine release from peripheral blood mononuclear cells of non-atopic women. J Biol Regul Homeost Agents 2010, 24(2):207-214.
40. Greulich C., et al. Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles. Acta Biomater 2011, 7(9):3505-3514.
41. Schmidt S., Moser M., Sperandio M. The molecular basis of leukocyte recruitment and its deficiencies. Mol Immunol 2013, 55(1):49-58.
42. Xie H., et al. Integrin alphavbeta3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy. Int J Nanomedicine 2011, 6:259-269.
43. Mantovani A., et al. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 2010, 21(1):27-39.
44. Teicher B.A., Fricker S.P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 2010, 16(11):2927-2931.
45. Cho W.S., et al. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 2012, 6(1):22-35.
46. Liu R., et al. The immune toxicity of titanium dioxide on primary pulmonary alveolar macrophages relies on their surface area and crystal structure. J Nanosci Nanotechnol 2010, 10(12):8491-8499.
47. Hanley C., et al. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res Lett 2009, 4(12):1409-1420.
48. Kennedy I.M., et al. Uptake and inflammatory effects of nanoparticles in a human vascular endothelial cell line. Res Rep Health Eff Inst 2009, 136:3-32.
49. Feltis B.N., et al. Independent cytotoxic and inflammatory responses to zinc oxide nanoparticles in human monocytes and macrophages. Nanotoxicology 2012, 6(7):757-765.